Şunu aradınız:: god bedring (Norveççe - İngilizce)

god
good

bedring i aql
aql improvement

behandling uten utsikt til bedring
futile treatments

utilstrekkelig bedring i faktor ixp,
inadequate factor ix recovery p, *

bedring (ie/dl per ie/kg)
recovery (iu/dl per iu/kg)

dersom bedring inntreffer, gjenoppta behandlingen.
if resolution occurs, resume therapy.d

avvent doser til bedring til ≤ grad 1,
withhold doses until improves to ≤ grade 1; resume at next lower dose levela

det er sett bedring etter seponering av mitotan.
improvement after mitotane discontinuation has been observed.

etter avsluttet behandling viste alle indikasjoner på toksisitet delvis til god bedring.
after treatment cessation, all indications of toxicity exhibited at least partial recovery to good recovery.

generelt sees bedring innen en uke etter behandlingsstart.
generally, improvement is seen within one week of starting treatment.

behandlingsvarighet baseres på bedring av nøytropeni eller immunsuppresjon.
duration of therapy is based on recovery from neutropenia or immunosuppression.

fullstendig bedring ble observert etter seponering av behandlingen:
complete recovery was seen after treatment discontinuation:

behandlingseffekten var drevet av bedring i komponenten symptomatisk progresjon.
the treatment effect was driven by improvement in the component symptomatic progression.

median tid til pasient bedring, ved legen (timer)
median time to overall patient improvement, by physician (hours)

behandlingen bør revurderes dersom man ikke ser bedring etter 5 dager.
the treatment should be re-considered if at 5 days no improvement in the clinical condition is observed.

det antas at disse symptomene skyldes en bedring i kroppens immunforsvar.
it is believed that these symptoms are due to a recovery of the body’s immune system.

doseringsfrekvensen bør initialt være hver 2. time inntil klinisk bedring er observert.
dosing frequency should initially be every second hour until clinical improvement is observed.

behandling bør seponeres senest etter 10 dager hvis klinisk bedring ikke registreres.
treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

behandlingen bør avbrytes senest etter 10 dager hvis det ikke oppnås noen klinisk bedring.
treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

behandlingen bør avbrytes etter senest 10 dagers behandling hvis det ikke oppnås klinisk bedring.
treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.